U.S. Gives Opinion On Qui Tam Pfizer Suit

Law360, New York (May 13, 2008, 12:00 AM EDT) -- The government has weighed in on Pfizer Inc.'s bid to dismiss a whistleblower lawsuit filed by a former executive alleging that the company illegally marketed human growth hormone Genotropin.

Under the False Claims Act, a complaint need not allege that the defendants made a false statement but merely that they caused a third party to make a false statement to get a false claim paid, said the motion filed Monday in the U.S. District Court for the District of Massachusetts.

“A statement urging a physician to...
To view the full article, register now.